Comparison of Computed Tomography Scoring Systems in Patients with COVID-19 and Hematological Malignancies

Simple Summary COVID-19 pneumonia poses a serious threat in hematologic patients. Computed tomography is an indispensable tool supporting diagnosis. A better and more objective analysis of the extent of pneumonia enables assessment of the extent of the disease as well as the selection of prognostic factors of death. The aim of this study is to compare four different computed tomography scoring systems (three semiquantitative and one qualitative) in hematology patients to better select patients at risk of death and choose the scoring system that is the most feasible for this group of patients. Abstract Background: Numerous computed tomography (CT) scales have been proposed to assess lung involvement in COVID-19 pneumonia as well as correlate radiological findings with patient outcomes. Objective: Comparison of different CT scoring systems in terms of time consumption and diagnostic performance in patients with hematological malignancies and COVID-19 infection. Materials and methods: Retrospective analysis included hematological patients with COVID-19 and CT performed within 10 days of diagnosis of infection. CT scans were analyzed in three different semi-quantitative scoring systems, Chest CT Severity Score (CT-SS), Chest CT Score(CT-S), amd Total Severity Score (TSS), as well as qualitative modified Total Severity Score (m-TSS). Time consumption and diagnostic performance were analyzed. Results: Fifty hematological patients were included. Based on the ICC values, excellent inter-observer reliability was found among the three semi-quantitative methods with ICC > 0.9 (p < 0.001). The inter-observer concordance was at the level of perfect agreement (kappa value = 1) for the mTSS method (p < 0.001). The three-receiver operating characteristic (ROC) curves revealed excellent and very good diagnostic accuracy for the three quantitative scoring systems. The AUC values were excellent (0.902), very good (0.899), and very good (0.881) in the CT-SS, CT-S and TSS scoring systems, respectively. Sensitivity showed high levels at 72.7%, 75%, and 65.9%, respectively, and specificity was recorded at 98.2%, 100%, 94.6% for the CT-SS, CT-S, and TSS scoring systems, respectively. Time consumption was the same for Chest CT Severity Score and TSS and was longer for Chest CT Score (p < 0.001). Conclusions: Chest CT score and chest CT severity score have very high sensitivity and specificity in terms of diagnostic accuracy. The highest AUC values and the shortest median time of analysis in chest CT severity score indicate this method as preferred for semi-quantitative assessment of chest CT in hematological patients with COVID-19.

[1]  Ahmed M. Salah,et al.  Chest CT Total Severity Score on Admission to Predict In-Hospital Mortality in COVID-19 Patients with Acute and Chronic Renal Impairment , 2022, Diagnostics.

[2]  K. Simon,et al.  Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of February 23, 2022. , 2022, Polish archives of internal medicine.

[3]  S. Mahmoudi,et al.  Chest CT severity score: assessment of COVID‑19 severity and short-term prognosis in hospitalized Iranian patients , 2022, Wiener Medizinische Wochenschrift.

[4]  A. Cieszanowski,et al.  Indications for imaging studies in SARS-CoV-2 infected patients – recommendations of the Polish Medical Society of Radiology , 2022, Polish journal of radiology.

[5]  Y. Eshet,et al.  Imaging of Hematological Patients in the Era of COVID-19 , 2022, Acta Haematologica.

[6]  A. Elmokadem,et al.  Comparison of chest CT severity scoring systems for COVID-19 , 2022, European Radiology.

[7]  M. Ceppi,et al.  Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis , 2021, Critical Reviews in Oncology/Hematology.

[8]  K. Simon,et al.  Management of SARS-CoV- infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. , 2021, Polish archives of internal medicine.

[9]  E. Cavigli,et al.  Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19 , 2021, Japanese Journal of Radiology.

[10]  B. Gulek,et al.  Different chest CT scoring systems in patients with COVID-19: could baseline CT be a helpful tool in predicting survival in patients with matched ages and co-morbid conditions? , 2021, Acta radiologica.

[11]  Wai Hoong Chang,et al.  Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study , 2020, BMJ Open.

[12]  H. Mansouritorghabeh,et al.  D-dimer level in COVID-19 infection: a systematic review , 2020, Expert review of hematology.

[13]  V. Jiménez‐Yuste,et al.  Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study , 2020, Journal of Hematology & Oncology.

[14]  C. Solano,et al.  Risk factors and outcome of COVID-19 in patients with hematological malignancies , 2020, Experimental Hematology & Oncology.

[15]  G. Corrao,et al.  Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study , 2020, The Lancet Haematology.

[16]  K. Sklinda,et al.  COVID-19 severity scoring systems in radiological imaging – a review , 2020, Polish journal of radiology.

[17]  C. Catalano,et al.  Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis , 2020, European Radiology.

[18]  Suqin Ben,et al.  Meta‐analysis of chest CT features of patients with COVID‐19 pneumonia , 2020, Journal of medical virology.

[19]  G. Di Lorenzo,et al.  Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy , 2020, Oncology.

[20]  Char Leung,et al.  Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China , 2020, Mechanisms of Ageing and Development.

[21]  Chaochao Tan,et al.  C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early , 2020, Journal of medical virology.

[22]  R. Ferrer.  Pandemia por COVID-19: el mayor reto de la historia del intensivismo , 2020, Medicina Intensiva.

[23]  Ran Yang,et al.  Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19 , 2020, Radiology. Cardiothoracic imaging.

[24]  Kunwei Li,et al.  CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) , 2020, European Radiology.

[25]  Mahmud Mossa-Basha,et al.  Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Panel , 2020, Radiology.

[26]  Chuanming Li,et al.  The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia , 2020, Investigative radiology.

[27]  Q. Tao,et al.  Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.

[28]  Z. Fayad,et al.  Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection , 2020, Radiology.

[29]  C. Zheng,et al.  Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia , 2020, Radiology.

[30]  P. Horby,et al.  A novel coronavirus outbreak of global health concern , 2020, The Lancet.

[31]  J. Austin,et al.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. , 1996, Radiology.

[32]  M. Aslan,et al.  Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in Turkey , 2021, Annals of Clinical and Analytical Medicine.